Related references
Note: Only part of the references are listed.Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4
Seng-Ryong Woo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection
Kirsten Richter et al.
INTERNATIONAL IMMUNOLOGY (2010)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Chrystelle Brignone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Jedd D. Wolchok et al.
LANCET ONCOLOGY (2010)
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Junko Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mycobacterium tuberculosis Peptides Presented by HLA-E Molecules Are Targets for Human CD8+ T-Cells with Cytotoxic as well as Regulatory Activity
Simone A. Joosten et al.
PLOS PATHOGENS (2010)
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
K. S. Peggs et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
Chrystelle Brignone et al.
CLINICAL CANCER RESEARCH (2009)
The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses
Alison Crawford et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
Tsvetelina Pentcheva-Hoang et al.
IMMUNOLOGICAL REVIEWS (2009)
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Joseph F. Grosso et al.
JOURNAL OF IMMUNOLOGY (2009)
LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
Creg J. Workman et al.
JOURNAL OF IMMUNOLOGY (2009)
Therapeutic potential of targeting BTLA
Alison Crawford et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2
Tomohisa Okamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lymphocyte activation gene-3 fusion protein increases the potency of a granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy
Betty Li et al.
CLINICAL CANCER RESEARCH (2008)
Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation
Chiara Casati et al.
JOURNAL OF IMMUNOLOGY (2008)
Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II
Bitao Liang et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells
Chrystelle Brignone et al.
JOURNAL OF IMMUNOLOGY (2007)
IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study
Chrystelle Brignone et al.
VACCINE (2007)
Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4
Simone A. Joosten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells
Jagadeesh Bayry et al.
JOURNAL OF IMMUNOLOGY (2007)
Proliferation of activated CD1d-restricted NKT cells is down-modulated by lymphocyte activation gene-3 signaling via cell cycle arrest in S phase
Hyun-Jung Byun et al.
CELL BIOLOGY INTERNATIONAL (2007)
Differential CD40/CD40L expression results in counteracting antitumor immune responses
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2007)
Metalloproteases regulate T-cell proliferation and effector function via LAG-3
Nianyu Li et al.
EMBO JOURNAL (2007)
A soluble LAG-3 protein as an immunopotentiator for therapeutic vaccines: Preclinical evaluation of IMP321
Sylvie Fougeray et al.
VACCINE (2006)
Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity
C Casati et al.
CANCER RESEARCH (2006)
A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors
F Triebel et al.
CANCER LETTERS (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
M Kisielow et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells
L Maçon-Lemaître et al.
IMMUNOLOGY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2004)
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223)
S Andreae et al.
BLOOD (2003)
The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells
CJ Workman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Cutting edge: Molecular analysis of the negative regulatory function of lymphocyte activation gene-3
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2002)
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223)
S Andreae et al.
JOURNAL OF IMMUNOLOGY (2002)
A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens
S El Mir et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
